progabide has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholini, G | 1 |
| Braendgaard, H; Dupont, E; Mondrup, K | 1 |
2 other study(ies) available for progabide and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Topics: 4-Aminobutyrate Transaminase; Basal Ganglia Diseases; Bicuculline; Dopamine; Dyskinesia, Drug-Induced; Epilepsy; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Limbic System; Neural Pathways; Neurons; Neurotransmitter Agents; Parkinson Disease; Psychopharmacology | 1979 |
Progabide in the treatment of hyperkinetic extrapyramidal movement disorders.
Topics: Adolescent; Adult; Aged; Athetosis; Basal Ganglia Diseases; Child; Chorea; Female; gamma-Aminobutyric Acid; Humans; Hyperkinesis; Male; Middle Aged; Myoclonus; Tourette Syndrome | 1985 |